Cognizant and Nvidia collaborate to accelerate AI adoption [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
The partnership will leverage Nvidia's advanced AI capabilities to drive innovation in five key areas. During the Nvidia GTC 2025 event, Cognizant outlined its plans to enhance its offerings in enterprise AI agents, industry-specific large language models (LLMs), digital twins for smart manufacturing, foundational infrastructure for AI, and the functionality of its Neuro AI platform. Cognizant's Neuro AI Multi-Agent Accelerator, powered by Nvidia's NIM microservices, is set to enable clients to rapidly build and scale multi-agent AI systems. These systems will support adaptive operations, real-time decision-making, and personalised customer experiences. The platform also allows seamless integration of third-party agent networks and most LLMs, providi
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- FDA Approves Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or BBusiness Wire
- InnovationRx: Fatal Drug Overdoses Are Falling – But Medicaid Cuts Could Halt Progress [Forbes]Forbes
- Biogen plots new global headquarters in Kendall Square [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $328.00 price target on the stock, up previously from $280.00.MarketBeat
- Stock market falls but S&P 500, Dow end week up. FedEx, Nike warn on outlooks [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 2/13/25 - Beat
ALNY
Sec Filings
- 3/25/25 - Form 4
- 3/25/25 - Form 4
- 3/24/25 - Form ARS
- ALNY's page on the SEC website